CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences net income
Net income is the profit left for shareholders after every expense, interest and tax.
CV Sciences's net income for the twelve months ending Sep 30, 2026 was -$1.72M. For fiscal 2025 it was -$958.00K. The highest annual figure on record is $10.00M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$958.00K | – |
| FY2024 | Dec 31, 2024 | -$2.39M | -177.2% |
| FY2023 | Dec 31, 2023 | $3.10M | – |
| FY2022 | Dec 31, 2022 | -$8.21M | – |
| FY2021 | Dec 31, 2021 | -$15.55M | – |
| FY2020 | Dec 31, 2020 | -$22.28M | – |
| FY2019 | Dec 31, 2019 | -$16.61M | -266.1% |
| FY2018 | Dec 31, 2018 | $10.00M | – |
| FY2017 | Dec 31, 2017 | -$4.90M | – |
| FY2016 | Dec 31, 2016 | -$14.14M | – |
| FY2015 | Dec 31, 2015 | -$12.23M | – |
| FY2014 | Dec 31, 2014 | -$1.31M | – |
| FY2013 | Dec 31, 2013 | -$2.30M | – |
| FY2012 | Dec 31, 2012 | -$45.61K | – |
| FY2011 | Dec 31, 2011 | -$90.18K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$93.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$775.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$643.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$206.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$382.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$261.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$109.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$726.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$456.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$584.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$628.00K | -111.0% |
| Q4 FY2023 | Dec 31, 2023 | -$869.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$447.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.29M | – |
| Q1 FY2023 | Mar 31, 2023 | $5.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.03M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.65M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.22M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.86M | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.13M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.29M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.68M | -480.9% |
| Q1 FY2020 | Mar 31, 2020 | -$5.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.69M | -330.5% |
| Q3 FY2019 | Sep 30, 2019 | -$1.77M | -153.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.23M | -61.4% |
| Q1 FY2019 | Mar 31, 2019 | -$9.38M | -1616.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.90M | +517.3% |
| Q3 FY2018 | Sep 30, 2018 | $3.30M | – |
| Q2 FY2018 | Jun 30, 2018 | $3.19M | – |
| Q1 FY2018 | Mar 31, 2018 | $619.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $469.95K | – |
| Q3 FY2017 | Sep 30, 2017 | -$589.98K | – |
| Q2 FY2017 | Jun 30, 2017 | -$992.19K | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.78M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.48M | – |
See a number that looks wrong?